Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Income from Discontinued Operations (2018 - 2019)

Analysis

Cerenome (CNSY) Income from Discontinued Operations (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn -
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn -
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn -
5 Revolution Medicines 44.41 Bn 44.41 Bn - -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -
10 Cerenome 20.42 Mn 11.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -36,000.00
Jun 30, 2019 -6.88 Mn
Mar 31, 2019 -686,000.00
Dec 31, 2018 -226,000.00
Sep 30, 2018 -934,000.00
Jun 30, 2018 -1.37 Mn